Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies.

Hdl Handle:
http://hdl.handle.net/10147/253499
Title:
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies.
Authors:
Cooney, Marie-Therese; Dudina, Alexandra; Whincup, Peter; Capewell, Simon; Menotti, Alessandro; Jousilahti, Pekka; Njølstad, Inger; Oganov, Raphel; Thomsen, Troels; Tverdal, Aage; Wedel, Hans; Wilhelmsen, Lars; Graham, Ian
Affiliation:
Department of Cardiology, Adelaide Meath Hospital, Tallaght, Dublin, Ireland.
Citation:
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. 2009, 16 (5):541-9 Eur J Cardiovasc Prev Rehabil
Publisher:
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
Journal:
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
Issue Date:
Oct-2009
URI:
http://hdl.handle.net/10147/253499
DOI:
10.1097/HJR.0b013e32832b38a1
PubMed ID:
19773660
Abstract:
Options for the prevention of cardiovascular disease, the greatest global cause of death, include population preventive measures (the Rose approach), or specifically seeking out and managing high-risk cases. However, the likely benefit of a population approach has been recently questioned.
Item Type:
Article
Language:
en
MeSH:
Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Biological Markers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cohort Studies; Europe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mass Screening; Middle Aged; Patient Compliance; Population Surveillance; Preventive Health Services; Risk Assessment; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Young Adult
ISSN:
1741-8275

Full metadata record

DC FieldValue Language
dc.contributor.authorCooney, Marie-Thereseen_GB
dc.contributor.authorDudina, Alexandraen_GB
dc.contributor.authorWhincup, Peteren_GB
dc.contributor.authorCapewell, Simonen_GB
dc.contributor.authorMenotti, Alessandroen_GB
dc.contributor.authorJousilahti, Pekkaen_GB
dc.contributor.authorNjølstad, Ingeren_GB
dc.contributor.authorOganov, Raphelen_GB
dc.contributor.authorThomsen, Troelsen_GB
dc.contributor.authorTverdal, Aageen_GB
dc.contributor.authorWedel, Hansen_GB
dc.contributor.authorWilhelmsen, Larsen_GB
dc.contributor.authorGraham, Ianen_GB
dc.date.accessioned2012-11-27T15:41:46Z-
dc.date.available2012-11-27T15:41:46Z-
dc.date.issued2009-10-
dc.identifier.citationRe-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. 2009, 16 (5):541-9 Eur J Cardiovasc Prev Rehabilen_GB
dc.identifier.issn1741-8275-
dc.identifier.pmid19773660-
dc.identifier.doi10.1097/HJR.0b013e32832b38a1-
dc.identifier.urihttp://hdl.handle.net/10147/253499-
dc.description.abstractOptions for the prevention of cardiovascular disease, the greatest global cause of death, include population preventive measures (the Rose approach), or specifically seeking out and managing high-risk cases. However, the likely benefit of a population approach has been recently questioned.en_GB
dc.language.isoenen
dc.publisherEuropean journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiologyen_GB
dc.rightsArchived with thanks to European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiologyen_GB
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAntihypertensive Agents-
dc.subject.meshAspirin-
dc.subject.meshBiological Markers-
dc.subject.meshBlood Pressure-
dc.subject.meshCardiovascular Diseases-
dc.subject.meshCholesterol-
dc.subject.meshCohort Studies-
dc.subject.meshEurope-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshHydroxymethylglutaryl-CoA Reductase Inhibitors-
dc.subject.meshMale-
dc.subject.meshMass Screening-
dc.subject.meshMiddle Aged-
dc.subject.meshPatient Compliance-
dc.subject.meshPopulation Surveillance-
dc.subject.meshPreventive Health Services-
dc.subject.meshRisk Assessment-
dc.subject.meshRisk Factors-
dc.subject.meshRisk Reduction Behavior-
dc.subject.meshSmoking-
dc.subject.meshSmoking Cessation-
dc.subject.meshTime Factors-
dc.subject.meshTreatment Outcome-
dc.subject.meshYoung Adult-
dc.titleRe-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Cardiology, Adelaide Meath Hospital, Tallaght, Dublin, Ireland.en_GB
dc.identifier.journalEuropean journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiologyen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.